H2020
EU-PEARL
EU Patient- cEntric clinicAl tRial pLatform
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 42 months
- Total cost
- EUR 25,655,310
- EU contribution
- EUR 12,004,953
- Participants
- 39 from 15 countries
- Topic
- H2020_IMI2-2018-15-01
- Grant agreement
- 853966
Coordinated by Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca (ESSpain).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca | ESSpain | Coordinator | EUR 2,182,245 | known name (0.97) |
| Medizinische Universitaet Wien | ATAustria | Participant | EUR 831,375 | PIC (1.00) |
| Custodix NV | BEBelgium | Participant | EUR 106,248 | PIC (1.00) |
| Forum des Patients Europeens | BEBelgium | Participant | EUR 459,250 | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Katholieke Universiteit Leuven | BEBelgium | Participant | EUR 186,375 | PIC (1.00) |
| The European Institute for Innovation Through Health Data | BEBelgium | Participant | EUR 751,625 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Bundesinstitut Fur Impfstoffe und Biomedizinische Arzneimittel | DEGermany | Participant | EUR 317,625 | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 539,000 | PIC (1.00) |
| European Aids Treatment Group Ev | DEGermany | Third party | Not stated | PIC (1.00) |
| Euroscan International Network Ev | DEGermany | Participant | EUR 117,500 | PIC (1.00) |
| Ludwig-Maximilians-Universitaet Muenchen | DEGermany | Participant | EUR 274,750 | PIC (1.00) |
| Otsuka Novel Products GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Novo Nordisk A/S | DKDenmark | Participant | EUR 0 | PIC (1.00) |
| Documental Ou | EEEstonia | Participant | EUR 129,158 | PIC (1.00) |
| Synapse Research Management Partners SL | ESSpain | Participant | EUR 97,700 | PIC (1.00) |
| Teamit Research SL | ESSpain | Participant | EUR 985,181 | PIC (1.00) |
| assistance publique hopitaux de paris | FRFrance | Participant | EUR 619,749 | name shared with others (0.80) |
| Ecrin European Clinical Research Infrastructure Network | FRFrance | Participant | EUR 426,875 | PIC (1.00) |
| Fondation Cardiometabolisme Nutrition | FRFrance | Third party | Not stated | PIC (1.00) |
| Institut de Recherches Internationales Servier | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Allergan Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Berry Consultants Llp | GBUnited Kingdom | Participant | EUR 196,250 | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 612,078 | known name (0.95) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 114,625 | PIC (1.00) |
| The University of Manchester | GBUnited Kingdom | Participant | EUR 40,000 | known name (0.95) |
| Teva Pharmaceutical Industries Limited | ILIsrael | Participant | EUR 0 | PIC (1.00) |
| Universita Degli Studi di Milano | ITItaly | Participant | EUR 145,250 | known name (0.95) |
| Universita Vita-Salute San Raffaele | ITItaly | Participant | EUR 734,250 | PIC (1.00) |
| Information Technology for Translational Medicine (Ittm) SA | LULuxembourg | Participant | EUR 184,970 | PIC (1.00) |
| Eatris Eric | NLNetherlands | Participant | EUR 775,625 | PIC (1.00) |
| Erasmus Universitair Medisch Centrum Rotterdam | NLNetherlands | Participant | EUR 899,875 | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | EUR 0 | PIC (1.00) |
| Abbvie Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Children's Tumor Foundation | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Global Alliance for Tb Drug Development Non Profit Organisation | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Springworks Therapeutics Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 39 participants from 15 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.